This clinical trial studies magnetic resonance imaging in planning radiation therapy in patients with liver, brain, head and neck, or pelvic cancer. Magnetic resonance imaging may help in planning radiation therapy and may result in more tumor cells being killed.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02045381.
PRIMARY OBJECTIVE:
I. To optimize magnetic resonance (MR) imaging protocols for radiation oncology patients with liver, brain, head and neck (H&N), and pelvic cancers undergoing computed tomography (CT)-based treatment planning.
SECONDARY OBJECTIVES:
I. To assess geometric distortion on a per-subject basis.
II. To optimize the use of new MR imaging sequences to aid in the classification of tissues for treatment planning.
III. To evaluate the accuracy of CT-less magnetic resonance imaging (MRI)-based planning as compared with current standard practice.
OUTLINE:
Patients undergo standard gadolinium-enhanced MRI over 45 minutes.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationUniversity of Michigan Rogel Cancer Center
Principal InvestigatorShruti Jolly
